English
简体中文
Total: £ 56.28
2026-04-13 | Pages: 119 | Tables: 123
The global Personalized Dietary Supplements market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economi...
2026-04-13 | Pages: 127 | Tables: 121
The global Tropical and Vector-borne Infectious Diseases market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the g...
2026-04-13 | Pages: 108 | Tables: 108
The global Animal Placental Protein market was valued at US$ 30.57 million in 2025 and is anticipated to reach US$ 41.16 million by 2032, at a CAGR of 4.4% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global...
2026-04-13 | Pages: 123 | Tables: 119
The global Carbohydrate Antigen 19-9 market was valued at US$ 112 million in 2025 and is anticipated to reach US$ 173 million by 2032, at a CAGR of 6.4% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global ec...
2026-04-13 | Pages: 116 | Tables: 108
The global Cutaneous Leishmaniasis Drugs market was valued at US$ 48.29 million in 2025 and is anticipated to reach US$ 63.72 million by 2032, at a CAGR of 4.1% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the g...
2026-04-13 | Pages: 121 | Tables: 125
The global Microencapsulation Technology market was valued at US$ 3077 million in 2025 and is anticipated to reach US$ 6170 million by 2032, at a CAGR of 10.6% from 2026 to 2032.Microencapsulation is a process in which tiny particles or droplets are ...
2026-04-13 | Pages: 112 | Tables: 117
The global Malignant Ascites Treatment market was valued at US$ 554 million in 2025 and is anticipated to reach US$ 766 million by 2032, at a CAGR of 4.8% from 2026 to 2032.The most common malignancies associated with the development of ascites inclu...
2026-04-13 | Pages: 121 | Tables: 122
The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market was valued at US$ 2256 million in 2025 and is anticipated to reach US$ 2018 million by 2032, at a CAGR of -1.6% from 2026 to 2032.The 2025 U.S. tariff policies introduce profou...
2026-04-13 | Pages: 134 | Tables: 132
The global Dry Eye Syndrome market was valued at US$ 6115 million in 2025 and is anticipated to reach US$ 8285 million by 2032, at a CAGR of 4.5% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic ...
2026-04-13 | Pages: 119 | Tables: 125
The global Head Lice Infestation Treatment market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic...
2026-04-13 | Pages: 115 | Tables: 110
The global Toxin market was valued at US$ 9334 million in 2025 and is anticipated to reach US$ 16710 million by 2032, at a CAGR of 8.8% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape....
2026-04-13 | Pages: 122 | Tables: 123
The global Proton Pump Inhibitors market was valued at US$ 11100 million in 2025 and is anticipated to reach US$ 8868 million by 2032, at a CAGR of -3.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global e...
2026-04-13 | Pages: 122 | Tables: 120
The global Fc Fusion Protein market was valued at US$ 39530 million in 2025 and is anticipated to reach US$ 79750 million by 2032, at a CAGR of 10.7% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econo...
2026-04-13 | Pages: 131 | Tables: 136
The global Probiotics for Weight Management market was valued at US$ 2535 million in 2025 and is anticipated to reach US$ 6576 million by 2032, at a CAGR of 14.8% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the...
2026-04-13 | Pages: 102 | Tables: 105
The global Norepinephrine (Noradrenaline) market was valued at US$ 548 million in 2025 and is anticipated to reach US$ 1184 million by 2032, at a CAGR of 11.8% from 2026 to 2032.Norepinephrine (NE), also called noradrenaline (NA) or noradrenalin, is ...
